In a collaboration, St. Jude scientists studied the adrenaline receptor at an atomic level. They identified amino acids controlling critical properties of the ligand. This receptor, part of the GPCR family, is crucial for many FDA-approved drugs. Understanding how GPCRs respond to natural or therapeutic ligands is vital for precise therapies.